within Pharmacolibrary.Drugs.ATC.V;

model V04CX07
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00028333333333333335,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V04CX07</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Edrophonium is a short-acting acetylcholinesterase inhibitor used primarily for the diagnosis of myasthenia gravis and in the evaluation of treatment response in similar neuromuscular disorders. Its rapid onset and short duration of action make it useful in diagnostic settings. It is not approved for chronic therapy and is largely of historical interest, as longer acting drugs are now preferred.</p><h4>Pharmacokinetics</h4><p>Estimated human adult parameters for intravenous administration; no specific population, age, or disease-related PK models published.</p><h4>References</h4><ol><li><p>Morris, RB, et al., &amp; Fahey, MR (1981). Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. <i>Anesthesiology</i> 54(5) 399–401. DOI:<a href=\"https://doi.org/10.1097/00000542-198105000-00009\">10.1097/00000542-198105000-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7224209/\">https://pubmed.ncbi.nlm.nih.gov/7224209</a></p></li><li><p>Back, DJ, &amp; Calvey, TN (1974). The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles. <i>British journal of pharmacology</i> 51(1) 61–65. DOI:<a href=\"https://doi.org/10.1111/j.1476-5381.1974.tb09632.x\">10.1111/j.1476-5381.1974.tb09632.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4216386/\">https://pubmed.ncbi.nlm.nih.gov/4216386</a></p></li><li><p>Buck, ML, &amp; Reed, MD (1991). Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients. <i>Clinical pharmacy</i> 10(1) 32–48. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1825627/\">https://pubmed.ncbi.nlm.nih.gov/1825627</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V04CX07;
